Study identifier:NIS-GVN-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese patients
Re-bleeding in NVUGIB
-
No
-
All
1044
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 May 2014 by AstraZeneca
AstraZeneca
-
The main aim of the study is to describes the outcomes of patients with Upper Gastrointestinal Bleed (UGIB) in a real-life setting. Additionally analyse assessed predictors of outcome, including the impact of hemostatic endoscopic and pharmacologic therapies.
MSD
Location
Location
Hanoi, Vietnam
Location
HoChiMinh City, Vietnam
Location
Danang, Vietnam
Arms | Assigned Interventions |
---|---|
1 | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.